
Matthew Gavidia

Matthew is an associate editor for The American Journal of Managed Care® (AJMC®). He joined AJMC® in 2019 and creates content for Medical World News®, a 24-hour online program developed MJH Life Sciences® focusing on pressing topics within managed care, as well as the nonwork-related activities of health care stakeholders.
He has a BA in journalism & media studies and economics from Rutgers University. You can connect with Matthew on LinkedIn.
Articles by Matthew Gavidia





A roundup of the latest news in sleep research reported across MJH Life Sciences™.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

High-Dose Methotrexate Effective in Preventing Isolated CNS Relapse in Diffuse Large B-Cell Lymphoma
Risk of isolated central nervous system (CNS) involvement was found to be significantly lower in patients with diffuse large B-cell lymphoma who received high-dose methotrexate vs RCHOP chemotherapy, although risk of concomitant CNS-systemic relapse rates were similar between both groups.

Jazz Pharmaceuticals’ Xywav oral solution is the first treatment to be approved for adults with idiopathic hypersomnia.

Results of the phase 3 REST-ON study exhibited significant improvement in patients with narcolepsy treated with once-nightly sodium oxybate, FT218, versus placebo.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Findings of the Adult Changes in Thought study present a significant link between long-term air pollution exposure and increased risk of dementia.

FDA approves avalglucosidase alfa-ngpt (Nexviazyme) for the treatment of patients 1 year and older with late-onset Pompe disease.

Ophthalmology Overview: Bevacizumab BLA in Wet AMD, Long COVID-19 and Corneal Nerve Damage, and More
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Taiwanese patients with uveitis were shown to be at greater risk of developing psoriasis and psoriatic arthritis than the general population, and hypertension, diabetes, and obesity were more prominent in these populations as well.

Patients with concurrent fatty liver disease and chronic hepatitis B exhibited higher cumulative rates of hepatitis B surface antigen seroclearance and lower cumulative rates of cirrhosis and hepatocellular carcinoma (HCC) across a 10-year period.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

People with high risk of obstructive sleep apnea presented with significant changes in key arteries indicative of accelerated vascular aging, a known contributor to cardiovascular disease (CVD).

A significant risk of neurodegenerative disease was found in an analysis of male former professional soccer players, with defensive outfield players and those with careers longer than 15 years particularly at risk.

On World Lung Cancer Day, we explore current guidelines for lung cancer screening in the United States, implications of the COVID-19 pandemic, and disparities in mortality and access to care by race and socioeconomic status.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

Patients with psoriatic arthritis and rheumatoid arthritis who were obese were shown to present with significantly lower quality of life (QOL) and worse disease activity than those with normal weight.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Higher physical activity and less time spent sitting and watching TV was associated with a significantly lower risk of developing obstructive sleep apnea.

People with prior incidence of traumatic brain injury and exposure to lead were shown to be at elevated risk of Parkinson disease development, with family history also found to influence risk.

The Academy of Sleep Medicine and the Sleep Research Society issued guiding principles for employers on designing optimal work shift durations in the workplace, which address risk factors, countermeasures, and shared decision-making implications.

New users of infliximab and adalimumab who had moderate to severe psoriasis exhibited an increased risk of hospitalization due to serious infection compared with etanercept users, with use of ustekinumab conversely linked with a decreased risk.

Patients with Parkinson disease treated with acupuncture-related therapies combined with conventional medication exhibited significant improvements in motor function and experiences of daily living, although the quality of findings may warrant future research.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

Low cardiorespiratory fitness among young adult men was significantly associated with an increased risk of psoriasis and psoriatic arthritis over 3 decades.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.




